The number of cancer patients is on the rise and standard therapies often fail. The reason for this is that every patient is different and due to tumor biology, therapy resistances develop over the course of the disease. As a solution, TheraMe! have developed an innovative tool that allows the efficacy of drugs and drug combinations to be tested directly on patients' tumor material within 24 hours in order to determine the best personalized therapy for the patient.